Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial (Q41758419)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 September 2014

Language	Label	Description	Also known as
English	Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial	scientific article published on 2 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

multicenter clinical trial

0 references

Stefan Rutkowski

4

object named as

S Rutkowski

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

author name string

U Bode

1

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

M Zimmermann

2

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

O Moser

3

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

M Warmuth-Metz

5

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

T Pietsch

6

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

R D Kortmann

7

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

A Faldum

8

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

G Fleischhack

9

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

2 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

120

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

635-642

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

https://scigraph.springernature.com/pub.10.1007/s11060-014-1598-8

0 references

Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

Molecular subgroups of medulloblastoma: the current consensus

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

Efficacy of High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Relapsed Medulloblastoma: A Report on The Korean Society for Pediatric Neuro-Oncology (KSPNO)-S-053 Study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

Treatment of recurrent central nervous system primitive neuroectodermal tumours in children and adolescents: results of a Children's Cancer and Leukaemia Group study.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1598-8

21 January 2018

High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[High-dose chemotherapy in relapse of medulloblastoma in young children]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy for recurrent medulloblastoma: time for a reappraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-014-1598-8

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41758419&oldid=1927334148"